Article Information
History
- July 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jan K. Nowak1,2,
- Rahul Kalla3,
- Alex T. Adams1,
- IBD-Character Consortium,
- Jonas Halfvarson4 and
- Jack Satsangi1,5,*
- 1Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
- 2Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland
- 3MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
- 4Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
- 5Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
- ↵*Corresponding author:
Prof. Jack Satsangi, jack.satsangi{at}ndm.ox.ac.uk, Translational Gastroenterology Unit, Experimental Medicine Division, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
Posted July 10, 2021.
Discovery of a simple two-gene expression biomarker in whole blood predictive of the need for treatment escalation in inflammatory bowel disease
